Cancer Trials Ireland Revenue and Competitors

Cancer Trials Ireland (formerly ICORG) gives patients early access to new cancer treatments, gained from innovative trial-based research, delivered with the most diligent medical care. Cancer Trials Ireland has been striving since 1996 to reach the highest level in the international cancer clinical research world, in 2016 the Group is now recognised as an important partner by many of the leading cancer treatment development agencies in the world, both from the academic and pharmaceutical sector. Today it counts more than 95% of Ireland's cancer treating consultants among its membership working together to develop some of the most exciting new treatments in some of the most challenging and complex areas of clinical research. We pride ourselves on the fact that our work is bringing these new research based treatment options to cancer patients in Ireland with 6727 patients on trial in 2015. With continued support and perseverance this figure is increasing all the time. While we are not-for-profit we enjoy the fact that it is a highly competitive and dynamic approach to what we do which has brought about our success. Last year Cancer Trials Ireland's contribution to the development of new treatments was recognised at 10 of the leading scientific meetings in the US and Europe. Today Cancer Trials Ireland's has 66 studies open for accrual and a further 88 in the follow up stage. Cancer Trials Ireland hopes to make a research option available to many more cancer patients in Ireland this year. Cancer Drug and Treatment Development, Phase I, II & III Clinical Trials, CT Project Management, CT Monitoring, CT Pharmacovigilance, CT Regulatory & Audit, CT Statistics & Data Management